|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Chiu, Chun-Lung | Chiu, Chun-Lung | Chiu, Chun-Lung | 02-26959935 | No. 80, Lane 169, Kang-Ning, St.,Hsi-Chih Dist., New Taipei City,TAIWAN, R.O.C. | 2008/05/21 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Level Biotechnology Inc. was founded in 1989. This company was originally set up for marketing and distributing cell culture, immunology, molecular biology products and biomedical precision equipments. We decided to establish CRO for preclinical services for NEC (New entity chemicals), medical device and other related products in 2000. Level Biotechnology Inc. is widely recognized as one of the top biotech companies offering excellent products and best preclinical CRO services in Taiwan. |
Market Information ( 2024/03/29 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
17.025 | 31.25 | 31.20 | 31.20 | 0.00 | 67 | .00 | 86 | 0 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/03/29) |
TPEx measures adopted (2024/03/29) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |